• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    Vanda Pharmaceuticals, Inc. (VNDA)

    -NasdaqGM
    8.64 Down 0.17(1.93%) Feb 5, 4:00PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
    Total Revenue 28,344   27,582   22,150   15,369  
    Cost of Revenue6,510  5,766  5,015  682  
    Gross Profit 21,834   21,816   17,135   14,687  
    Operating Expenses
    Research Development9,974  5,946  4,478  4,751  
    Selling General and Administrative18,458  18,386  18,806  17,323  
    Non Recurring -   -   -   -  
    Others2,943  2,942  4,144  536  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (9,541) (5,458) (10,293) 69,693  
    Income from Continuing Operations
    Total Other Income/Expenses Net81  72  72  77,642  
    Earnings Before Interest And Taxes(9,460)(5,386)(10,221)147,335  
    Interest Expense -   -   -   -  
    Income Before Tax(9,460)(5,386)(10,221)147,335  
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(9,460)(5,386)(10,221)147,335  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (9,460) (5,386) (10,221) 69,719  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (9,460) (5,386) (10,221) 69,719  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.